Better Buy: 10x Genomics vs. DermTech

If you are looking to invest in companies that aim to provide disruptive technology to the healthcare sector, there can be plenty of intriguing options. While some of those may lack a solid foundation to build a high-quality business on, 10x Genomics (NASDAQ: TXG) and DermTech (NASDAQ: DMTK) don't suffer from that issue, and each is well worth your consideration.

Both have immense potential, but which stock is a better buy today? Two Motley Fool contributors battle it out to answer this question. 

Image Source: Getty Images.

Continue reading

Source Fool.com